Clinical Trial

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”),…

4 weeks ago

Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium

MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

4 weeks ago

Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health solution using an AI-powered wearable device for the early detection of epileptic seizures

A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection of seizure risk in real…

4 weeks ago

Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two

Calgary, Alberta--(Newsfile Corp. - November 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), is pleased to announce…

4 weeks ago

Mural Health Expands Offering to Include Meal Delivery Services for Clinical Trial Participants

BERWYN, Pa., Nov. 26, 2025 /PRNewswire/ -- Mural Health Technologies, Inc., a patient-first clinical trial technology company, today announced the expansion…

4 weeks ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics…

4 weeks ago

Subtle Medical Doubles Growth; Showcases New Releases and Strengthened Partnerships at RSNA 2025

Subtle's Latest Solutions Set New Benchmarks for AI-powered Acceleration, Image Quality, and OrganizationMENLO PARK, Calif., Nov. 26, 2025 /PRNewswire/ --…

4 weeks ago

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a…

4 weeks ago

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a…

4 weeks ago

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.…

4 weeks ago